Početna stranicaAPNHY • OTCMKTS
add
Aspen Pharmacare Holdings ADR
Preth. zaklj. cijena
9,42 $
Dnevni raspon
9,65 $ - 9,65 $
Godišnji raspon
9,42 $ - 13,69 $
Tržišna kapitalizacija
75,89 mlr. ZAR
Prosječna količina
174,00
U vijestima
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (ZAR) | lip 2024.info | Godišnja promjena |
|---|---|---|
Prihod | 11,78 mlr. | 9,30 % |
Operativni troškovi | 2,36 mlr. | −3,24 % |
Neto dohodak | 1,04 mlr. | −18,17 % |
Neto profitabilnost | 8,87 | −25,15 % |
Zarada po dionici | — | — |
EBITDA | 2,93 mlr. | 7,80 % |
Efektivna porezna stopa | 25,52 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (ZAR) | lip 2024.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 12,34 mlr. | 13,06 % |
Ukupna imovina | 139,16 mlr. | 3,63 % |
Ukupne obveze | 54,29 mlr. | 13,00 % |
Ukupni kapital | 84,86 mlr. | — |
Dionice u optjecaju | 444,21 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 0,05 | — |
Povrat imovine | 4,84 % | — |
Povrat kapitala | 5,56 % | — |
Tok novca
Neto promjena novca
| (ZAR) | lip 2024.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 1,04 mlr. | −18,17 % |
Gotovina od poslovanja | 1,88 mlr. | −1,21 % |
Gotovina iz ulaganja | −1,65 mlr. | −79,92 % |
Gotovina iz financiranja | −141,50 mil. | 52,91 % |
Neto promjena novca | −200,00 mil. | −118,37 % |
Slobodan tok novca | 525,31 mil. | −32,86 % |
Više
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
Glavni izvršni direktor
Osnovano
1850
Web-lokacija
Zaposlenici
9.109
